Literature DB >> 10436159

Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase.

M Maekawa1, T Ishizaki, S Boku, N Watanabe, A Fujita, A Iwamatsu, T Obinata, K Ohashi, K Mizuno, S Narumiya.   

Abstract

The actin cytoskeleton undergoes extensive remodeling during cell morphogenesis and motility. The small guanosine triphosphatase Rho regulates such remodeling, but the underlying mechanisms of this regulation remain unclear. Cofilin exhibits actin-depolymerizing activity that is inhibited as a result of its phosphorylation by LIM-kinase. Cofilin was phosphorylated in N1E-115 neuroblastoma cells during lysophosphatidic acid-induced, Rho-mediated neurite retraction. This phosphorylation was sensitive to Y-27632, a specific inhibitor of the Rho-associated kinase ROCK. ROCK, which is a downstream effector of Rho, did not phosphorylate cofilin directly but phosphorylated LIM-kinase, which in turn was activated to phosphorylate cofilin. Overexpression of LIM-kinase in HeLa cells induced the formation of actin stress fibers in a Y-27632-sensitive manner. These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10436159     DOI: 10.1126/science.285.5429.895

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  539 in total

Review 1.  Rho GTPases and their effector proteins.

Authors:  A L Bishop; A Hall
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

2.  Post-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts.

Authors:  Geraldine Pawlak; David M Helfman
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

3.  Escherichia coli cytotoxic necrotizing factor and Pasteurella multocida toxin induce focal adhesion kinase autophosphorylation and Src association.

Authors:  W Thomas; G D Pullinger; A J Lax; E Rozengurt
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

4.  Angiostatin effects on endothelial cells mediated by ceramide and RhoA.

Authors:  N Gupta; E Nodzenski; N N Khodarev; J Yu; L Khorasani; M A Beckett; D W Kufe; R R Weichselbaum
Journal:  EMBO Rep       Date:  2001-06       Impact factor: 8.807

5.  Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 Gene.

Authors:  W Thomas; Z K Ascott; D Harmey; L W Slice; E Rozengurt; A J Lax
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

6.  Ezrin function is required for ROCK-mediated fibroblast transformation by the Net and Dbl oncogenes.

Authors:  C Tran Quang; A Gautreau; M Arpin; R Treisman
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

7.  Control of growth cone motility and morphology by LIM kinase and Slingshot via phosphorylation and dephosphorylation of cofilin.

Authors:  Mitsuharu Endo; Kazumasa Ohashi; Yukio Sasaki; Yoshio Goshima; Ryusuke Niwa; Tadashi Uemura; Kensaku Mizuno
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

8.  Modulation of fibroblast morphology and adhesion during collagen matrix remodeling.

Authors:  Elisa Tamariz; Frederick Grinnell
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

9.  Loss of cell-cell contacts induces NF-kappaB via RhoA-mediated activation of protein kinase D1.

Authors:  Catherine F Cowell; Irene K Yan; Tim Eiseler; Amanda C Leightner; Heike Döppler; Peter Storz
Journal:  J Cell Biochem       Date:  2009-03-01       Impact factor: 4.429

10.  Inhibition of Diaphanous Formin Signaling In Vivo Impairs Cardiovascular Development and Alters Smooth Muscle Cell Phenotype.

Authors:  Laura Weise-Cross; Joan M Taylor; Christopher P Mack
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-09-17       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.